blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2152702

EP2152702 - AMINO-THIAZOLYL- PYRIMIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.06.2012
Database last updated on 02.11.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2010/07]
Inventor(s)01 / ALMEIDA, Lynsie
AstraZeneca R & D Boston 35 Gatehouse Drive
Waltham, Massachusetts 02451 / US
02 / GUAN, Huiping
AstraZeneca R & D Boston 35 Gatehouse Drive
Waltham, Massachusetts 02451 / US
03 / IOANNIDIS, Stephanos
AstraZeneca R & D Boston 35 Gatehouse Drive
Waltham, Massachusetts 02451 / US
04 / LAMB, Michelle
AstraZeneca R & D Boston 35 Gatehouse Drive
Waltham, Massachusetts 02451 / US
05 / PENG, Bo
AstraZeneca R & D Boston 35 Gatehouse Drive
Waltham, Massachusetts 02451 / US
 [2010/07]
Application number, filing date08737246.202.05.2008
[2010/07]
WO2008GB50322
Priority number, dateUS20070915966P04.05.2007         Original published format: US 915966 P
[2010/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008135786
Date:13.11.2008
Language:EN
[2008/46]
Type: A1 Application with search report 
No.:EP2152702
Date:17.02.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 13.11.2008 takes the place of the publication of the European patent application.
[2010/07]
Type: B1 Patent specification 
No.:EP2152702
Date:24.08.2011
Language:EN
[2011/34]
Search report(s)International search report - published on:EP13.11.2008
ClassificationIPC:C07D417/12, C07D417/14, A61K31/506, A61P35/00
[2010/07]
CPC:
C07D417/12 (EP,US); A61P13/12 (EP); A61P17/06 (EP);
A61P19/08 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07D417/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/07]
TitleGerman:AMINOTHIAZOLYLPYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON KREBS[2010/07]
English:AMINO-THIAZOLYL- PYRIMIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER[2010/07]
French:DÉRIVÉS D'AMINO-THIAZOLYL-PYRIMIDINE ET LEUR UTILISATION POUR LE TRAITEMENT DU CANCER[2010/07]
Entry into regional phase04.12.2009National basic fee paid 
04.12.2009Designation fee(s) paid 
04.12.2009Examination fee paid 
Examination procedure04.12.2009Examination requested  [2010/07]
09.02.2010Despatch of a communication from the examining division (Time limit: M06)
16.08.2010Reply to a communication from the examining division
03.01.2011Communication of intention to grant the patent
15.04.2011Fee for grant paid
15.04.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.02.2010
Opposition(s)25.05.2012No opposition filed within time limit [2012/31]
Fees paidRenewal fee
31.05.2010Renewal fee patent year 03
31.05.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU02.05.2008
AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
MT24.08.2011
PL24.08.2011
RO24.08.2011
SI24.08.2011
SK24.08.2011
BG24.11.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
IE02.05.2012
LU02.05.2012
[2014/34]
Former [2014/27]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
MT24.08.2011
PL24.08.2011
RO24.08.2011
SI24.08.2011
SK24.08.2011
BG24.11.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
IE02.05.2012
LU02.05.2012
Former [2013/35]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
MT24.08.2011
PL24.08.2011
RO24.08.2011
SI24.08.2011
SK24.08.2011
BG24.11.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
IE02.05.2012
Former [2013/29]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
PL24.08.2011
RO24.08.2011
SI24.08.2011
SK24.08.2011
BG24.11.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
IE02.05.2012
Former [2013/20]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
PL24.08.2011
RO24.08.2011
SI24.08.2011
SK24.08.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
IE02.05.2012
Former [2012/34]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
PL24.08.2011
RO24.08.2011
SI24.08.2011
SK24.08.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
Former [2012/23]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
EE24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
PL24.08.2011
RO24.08.2011
SI24.08.2011
SK24.08.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
Former [2012/21]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
PL24.08.2011
SI24.08.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
Former [2012/17]AT24.08.2011
BE24.08.2011
CY24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
PL24.08.2011
SI24.08.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
Former [2012/13]AT24.08.2011
CY24.08.2011
FI24.08.2011
HR24.08.2011
LT24.08.2011
LV24.08.2011
PL24.08.2011
SI24.08.2011
NO24.11.2011
GR25.11.2011
IS24.12.2011
PT26.12.2011
Cited inInternational search[A]WO2006115452  (ASTRAZENECA AB [SE], et al) [A] 1-30 * page 1, line 10 - page 3, line 19 * * Examples; page 29 - page 42 ** claim 1 *;
 [A]WO2006123113  (ASTRAZENECA AB [SE], et al) [A] 1-30 * page 1, line 10 - page 2, line 20 * * page 35 - page 48; examples 1-38 * * claim 1 *;
 [A]WO2007049041  (ASTRAZENECA AB [SE], et al) [A] 1-30 * page 1, line 11 - page 4, line 11 * * page 40 - page 55; examples 1-37 * * claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.